Even better is the fact that the new contracts over the last year or so are spread across the country
in both the IDN and academic sectors. And PME has maintained its premium price
structure highlighting the lead the company has over the competition. Still to come is the company's participation in this year's November RSNA trade show where the new cardiology
imaging product will be launched. Expect even more interest in RMD's offerings after this event.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.69 |
Change
3.010(0.96%) |
Mkt cap ! $33.18B | |||
| Open | High | Low | Value | Volume |
| $319.39 | $325.00 | $316.78 | $73.46M | 230.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 225 | $317.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $320.05 | 734 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |